Who owns Oncternal Therapeutics Inc?
- Ticker: ONCT
- CUSIP Number: 68236p107
Tip: Access positions for across all investors
Analyze quarterly positions in Oncternal Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Oncternal Therapeutics stock
Who bought or sold Oncternal Therapeutics Inc this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Vanguard Group | 2.9M | $1.5M | 0% | Dec 2023 |
|
Millennium Management | 2.1M | $1.1M | 25% | Dec 2023 |
|
BlackRock | 786k | $236k | 0% | Sep 2023 |
|
Pasadena Private Wealth | 500k | $268k | 79% | Dec 2023 |
|
Richmond Brothers | 494k | $265k | 0% | Dec 2023 |
|
Geode Capital Management | 476k | $144k | 15% | Sep 2023 |
|
Renaissance Technologies | 313k | $94k | 9% | Sep 2023 |
|
LPL Financial | 172k | $51k | 0% | Sep 2023 |
|
State Street Corporation | 161k | $49k | 0% | Sep 2023 |
|
Ieq Capital | 144k | $77k | 0% | Dec 2023 |
|
Morgan Stanley | 98k | $29k | 0% | Sep 2023 |
|
Northern Trust | 85k | $25k | 0% | Sep 2023 |
|
Two Sigma Advisers | 84k | $45k | -15% | Dec 2023 |
|
Two Sigma Investments | 75k | $40k | 0% | Dec 2023 |
|
Acadian Asset Management | 73k | $21k | -33% | Sep 2023 |
|
Axxcess Wealth Management | 70k | $38k | 0% | Dec 2023 |
|
Two Sigma Securities | 59k | $32k | 177% | Dec 2023 |
|
Citadel Advisors | 54k | $29k | 100% | Dec 2023 |
|
Envestnet Asset Management | 54k | $16k | 0% | Sep 2023 |
|
Regents of the University of California | 54k | $29k | 0% | Dec 2023 |
|
Balboa Wealth Partners | 48k | $26k | 0% | Dec 2023 |
|
Creative Planning | 39k | $21k | 0% | Dec 2023 |
|
Charles Schwab Investment Management | 32k | $17k | 0% | Dec 2023 |
|
Beta Wealth | 32k | $17k | 0% | Dec 2023 |
|
IPG Investment Advisors | 23k | $13k | 100% | Dec 2023 |
|
Susquehanna International | 22k | $6.8k | 20% | Sep 2023 |
|
Jpmorgan Chase & Co | 20k | $10k | 0% | Dec 2023 |
|
Tower Research Capital | 19k | $5.8k | -34% | Sep 2023 |
|
Advisor Group Holdings | 8.9k | $4.7k | -29% | Dec 2023 |
|
Wells Fargo & Company | 6.4k | $3.4k | 0% | Dec 2023 |
|
Bnp Paribas Arbitrage, Snc | 3.6k | $2.0k | 0% | Dec 2023 |
|
UBS Group | 2.0k | $1.1k | -85% | Dec 2023 |
|
Column Capital Advisors | 1.5k | $435.000000 | 0% | Sep 2023 |
|
Truvestments Capital | 440.00 | $132.000000 | 0% | Sep 2023 |
|
Steward Partners Investment Advisory | 300.00 | $161.010000 | 0% | Dec 2023 |
|
Bank of America Corporation | 35.00 | $19.001500 | -99% | Dec 2023 |
|
Coppell Advisory Solutions | 20.00 | $11.000000 | -66% | Dec 2023 |
|
Cetera Trust Company | 7.00 | $3.999800 | 100% | Dec 2023 |
|
Delta Asset Management | 7.00 | $3.999800 | 0% | Dec 2023 |
|
Qube Research & Technologies | 1.00 | $0 | 100% | Sep 2023 |
|
Who sold out of Oncternal Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Quantum Private Wealth | Sep 2023 | 459k | $138k |
Brighton Jones | Sep 2023 | 339k | $102k |
CI Private Wealth | Sep 2023 | 92k | $28k |
Mercer Global Advisors | Sep 2023 | 54k | $16k |
Valeo Financial Advisors | Sep 2023 | 35k | $10k |
Aureus Asset Management | Sep 2023 | 30k | $9.1k |
Waypoint Capital Advisors | Sep 2023 | 26k | $7.9k |
Mackenzie Financial | Sep 2023 | 20k | $6.0k |
Bank of New York Mellon | Sep 2023 | 18k | $5.3k |
Resources Investment Advisors | Jun 2023 | 12k | $4.0k |
Jane Street | Sep 2023 | 10k | $3.1k |
Baader Bank | Sep 2023 | 10k | $2.7k |
North Star Investment Management | Sep 2023 | 10k | $3.0k |
Royal Bank of Canada | Sep 2023 | 10k | $3.0k |
Lindbrook Capital | Sep 2023 | 300.00 | $90.000000 |
Nemes Rush Group | Sep 2023 | 71.00 | $22.002900 |